Injectable Drug Delivery News

  1. Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement To Develop AVERSA™ Fentanyl, An Abuse Deterrent Fentanyl Patch 1/10/2022

    The feasibility agreement is focused on adapting Kindeva’s commercial transdermal manufacturing process to incorporate AVERSA technology.

  2. Baxter Announces $100 Million Investment In BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility 11/11/2021

    This facility is operated by BioPharma Solutions (BPS), a business unit of Baxter that specializes in partnering with leading pharmaceutical and biotech companies on the development and contract manufacturing of drug product for parenteral (injectable) pharmaceuticals.

  3. Baxter BioPharma Solutions Announces $50 Million Investment To Expand Sterile Fill/Finish Manufacturing Site In Bloomington, Ind. 11/24/2020

    These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed.